US Patent Issued to Legend Biotech Ireland, Legend Biotech USA on March 31 for "CD20 binding molecules and uses thereof" (Chinese, Canadian Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,166, issued on March 31, was assigned to Legend Biotech Ireland Ltd. (Dublin) and Legend Biotech USA Inc. (Somerset, N.J.).

"CD20 binding molecules and uses thereof" was invented by Xiaohu Fan (Edmonton, Canada), Zhe Zhou (Nanjing, China), Qiuchuan Zhuang (Nanjing, China), Xu Fang (Nanjing, China), Hongbo Pan (Nanjing, China), Min Wei (Nanjing, China) and Jianrui Zhu (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides single domain antibodies that bind to CD20, and chimeric antigen receptors comprising same. Further provided are engineered immune effector cells (such as T cells) comprising the chimeric ant...